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Abstract 
Background 
Pilonidal sinus disease (PNS) is not uncommon in children. Controversy remains over the 
best treatment and there is limited evidence. This systematic review and meta-analysis aims 
to establish which techniques have the best outcomes in children. 
Methods 
MEDLINE, EMBASE and CENTRAL databases were searched. Studies reporting treatment 
outcomes for PNS in children were included.  
Results 
Open healing has pooled risk of recurrence of 26% (95%CI 15-38%), risk of wound 
complication of 21% (9-36%) and wound healing ranged from 38-92 days. Midline primary 
closure has pooled risk of recurrence of 12% (8-18%), risk of wound complication of 30% 
(19-46%) and wound healing ranged from 8-32 days. Off-midline primary closure has pooled 
risk of recurrence of 6% (1-15%), risk of wound complication of 14% (6-25%) and wound 
healing was 27 days.  VAC therapy has pooled risk of recurrence of 20% (0-65%) and 
wound healing ranged from 38-92 days.  Minimally invasive techniques has pooled risk of 
recurrence of 7% (1-16%) and wound healing ranged from 21-30 days.  Marsupialisation has 
pooled risk of recurrence of 6% (0-22%), and wound healing ranged from 6-41 days.  
Conclusion 
Evidence for management of PNS in children is poor. Off-midline primary closure, minimally 
invasive techniques, and marsupialisation have the best outcomes. 
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1. Introduction 
 
Sacrococcygeal pilonidal sinus disease (PNS)1 is not uncommon in children [1,2]. Onset is 
usually around the time of puberty. Symptoms such as recurrent acute abscess and chronic 
suppuration may have significant impact on patients’ quality of life [4], education and social 
integration [2,3]. The ideal treatment for this condition should cause minimal disruption or 
discomfort whilst having good cure and recurrence rates.  
Systematic reviews and meta-analyses [4,5] in the treatment of adult PNS have indicated 
wide excision and healing by secondary intention has the lowest long term recurrence, whilst 
excision with primary closure via an off-midline or flap technique have quicker healing and 
only slightly less favourable recurrence rates. These approaches involve significant tissue 
loss, a hospital admission often of several days[2] and a long time (14-60 days) until return 
to normal activities [6,7].  
More recently minimally invasive techniques including fibrin glue obliteration [8,9], minimal 
excision [10], endoscopic [11,12] and crystallized phenol [13] and have been described in 
both adults and children. These treatments reportedly offer quicker healing and return to 
normal activities with acceptable recurrence rates. However, long term follow-up data is 
absent. 
The treatment of PNS in children has generally mirrored that in adults, but there has been 
little research in in children [1,14].  It is not well understood whether adult outcomes can be 
generalised to children; indeed some studies have indicated that long term recurrence rates 
are higher in patients where surgery is required at an earlier age [15]. This may be due to a 
genetic predisposition to developing the disease, or that PNS presenting in childhood tends 
to be more severe or that the conditions predisposing to PNS are present for a longer period.  
Furthermore, as surgical interventions in children may impact on schooling, sporting 
                                                          
1 PNS – pilonidal sinus disease 
activities and social integration, different outcome priorities may exist for treatment in this 
age group. 
We have therefore carried out a systematic review and meta-analysis of all published 
evidence regarding the treatment of pilonidal sinus disease in the paediatric population with 
the aim of establishing which techniques have the best outcomes for recurrence, wound 
healing, wound complications, and which are most acceptable to patients. We also looked 
for evidence on quality of life and time to return to normal activities.  
 
2. Method 
Study design 
This systematic review was registered prospectively with PROSPERO (registration number 
CRD42018095297) and was carried out in accordance with the PRISMA statement [16]. Any 
study reporting treatment outcomes for sacrococcygeal PNS in a population with median age 
of 18 or under were included. The minimum outcome reporting required for inclusion was 
recurrence rate. Studies which did not report treatment outcomes, reported non 
sacrococcygeal PNS or reported outcomes in an adult population (median age >18) were 
excluded. 
Literature search 
Literature searches were carried out by a trained Clinical Research Librarian using the 
following databases: MEDLINE, EMBASE and CENTRAL (all searched from their inception 
to 17th May 2018). No language or date restriction was applied to the searches. The 
Cochrane Library of Systematic Reviews was searched for relevant reviews and the 
abstracts from the conference proceedings of the British Society of Paediatric Surgeons for 
the last 10 years were searched for relevant unpublished studies. Previous systematic 
reviews of related topics were also searched for relevant studies. References of identified 
potentially relevant studies were hand-searched for further studies. Finally, all studies citing 
the identified potentially relevant primary studies identified on Google Scholar were screened 
for inclusion. Example search strategies can be found in Appendix A. 
 
Abstracts were screened independently by two authors (EH and PH) with the aid of Rayyan 
systematic review software (2016, Qatar Computing Research Institute, Doha, Qatar) [17] 
and considered for full text review if either author deemed them to be potentially relevant. A 
grey literature search as described above was completed by one author (RR). Full text 
versions of all potentially relevant primary studies were then independently screened against 
the inclusion and exclusion criteria by two authors (EH and PH) and agreement to inclusion 
reached by consensus.  
Data extraction 
Study characteristics and outcome data were independently extracted and verified by two 
authors (EH and HP). Risk of bias for included studies was assessed independently by two 
authors using the Risk of Bias In Non-randomized Studies – of Interventions (ROBINS-I) 
assessment tool [18] (EH and PH) with any disagreement resolved by consensus.  
Statistical analysis 
All analyses were conducted in STATA Version 15 (StataCorp LLC, Texas). We used the 
metaprop user-written. Effect estimates are presented as proportions with 95% confidence 
intervals (CI) as none of the included studies reported outcomes as time to event. Pooled 
estimates were calculated using the Freeman-Tukey double arcsine transformation and CIs 
were calculated using the exact method. We used random effects models due to the clinical 
heterogeneity between the included studies. Statistical heterogeneity was assessed using 
the I2 statistic. To assess the association between follow up time and rate of recurrence we 
used a maximum likelihood random effects meta-regression with the Knapp Hartung 
modification. To assess publication bias, if ten or more studies were included we conducted 
Egger’s linear regression test. Due to the previously published problems with conventional 
tests for publication bias and proportion outcomes we used study size rather than standard 
errors on the Y axis [19].  
 
 
3. Results 
A total of 5128 potentially relevant abstracts were screened for inclusion, of which 2664 were 
unique papers. Of the 2664 unique abstracts screened, 41 studies were identified for full text 
review. Following full text review a further 15 studies were excluded as they either did not 
report recurrence rates, did not clearly report which surgical technique was used or were 
performed in adults. Twenty six studies were included in the qualitative synthesis and 23 in 
the quantitative analysis (Figure 1). 
Study characteristics 
The characteristics of included studies are shown in Table 1. No studies published before 
2002 met the criteria for inclusion. All studies had full texts published in peer reviewed 
journals. All included studies were retrospective case series or cohort studies. Eleven case 
series reported the results of one surgical intervention alone, whilst a further 11 cohort 
studies compared results of 2 different interventions, and 4 papers reported the results of 3 
different surgical intervention.  Sample sizes ranged from 8 to 268 patients. Only 4 studies 
reported outcomes of over 50 patients for any one intervention, and only 3 studies included a 
total of over 100 patients.  
All but 1 study were single centre studies. Ten studies were based in the USA, 5 studies 
were from Turkey, 2 from each of the UK, Israel, Italy and Canada and 1 each from Spain 
and Italy. Ethnicity of subjects was not reported in any study. 
Median follow-up ranged from 39 days to 54 months. Nine studies reported results with a 
median follow up of over 12 months.  
Risk of bias 
Risk of bias was assessed using the ROBIN-I tool (Table 2). Fifteen studies were considered 
at moderate risk of bias with regard to confounding factors as they had performed no 
appropriate analysis to adjust for any important confounding factors. The remaining 11 
studies were found to be at severe risk in this domain as they had not appropriately 
controlled for potentially important confounding factors and performed no appropriate 
statistical adjustment. Eleven studies were judged to be at moderate or severe risk of 
selection bias as they either did not report selection criteria or selection was based on 
surgical preference. Two studies were judged to be at serious risk of bias with regard to 
classification of intervention as they grouped several procedures together in reporting 
outcomes. One study was at serious risk of bias due to deviation from intended intervention 
as a random selection of patients receiving laser epilation in addition to the primary 
intervention, with no reporting of the outcomes for this subset or how these patients were 
distributed between the 2 groups of primary intervention. All studies were at moderate risk of 
bias in measurement of outcomes and reporting results as all were non-blinded studies and 
none had a predefined set of outcomes to be reported.   
Overall sixteen studies were found to be at severe risk of bias, whilst the remaining ten 
studies were at moderate risk. 
Data synthesis 
All 26 included studies reported recurrence rates, whilst 18 reported wound complication 
rates, allowing these outcomes to be included in meta-analysis. Only 14 studies reported 
outcomes for time to wound healing and where reported it was of insufficient detail to allow 
further analysis.  Seven studies reported a measure of patient satisfaction, but the reported 
measure was highly variable and no studies used any validated quality of life or patient 
satisfaction measure.  Results are summarised in table 3. 
Open healing 
Six studies reported the outcomes of open healing for 191 patients. All papers were 
comparative cohort studies, of which 1 study compared open healing to minimally invasive 
techniques [12], 1 compared open healing to marsupialisation [1], 2 compared open healing 
to off-midline primary closure [20,21] and 4 compared open healing to midline primary 
closure [1,21,22]. Overall pooled risk of recurrence (Figure 2) was 26% (95% CI 15-38%). 
When analysed as a subgroup, studies with median follow-up of over 12 months had a 
pooled risk of recurrence of 32% (13-53%). There was moderate statistical heterogeneity 
(I2=54.6%). Wound complications were reported by 3 studies [12,20,21] and the pooled risk 
of wound complication was 21% (9-36%, I2=36.1%) (Figure 3). Average time to wound 
healing ranged from 38 to 92 days, but was not reported in enough detail to allow pooled 
analysis.  Meta regression analysis, assessing the relationship between length of follow-up 
and incidence of recurrence, appeared to show a relationship, but this did not reach 
statistical significance (Fig 4). There was no statistical evidence of publication bias (Egger’s 
test p=0.996).   
Midline primary closure 
Sixteen studies reported the outcomes of midline primary closure for a total of 728 
individuals. Five studies were case series which reported the outcome of midline primary 
closure alone [14,23–26]. Five comparative cohort studies compared midline primary closure 
to off-midline primary closure [2,8,21,27,28], 4 compared it to open healing [1,21,22,29], 3 
compared it to minimally invasive techniques [8,13,30], and 2 to marsupialisation [1,31]. 
Overall risk of recurrence was 12% (8-18%), and in studies with over 12 months follow up 
pooled risk of recurrence was 13% (4-24%) (Figure 5). There was substantial heterogeneity 
between groups (I2 =62.2%). Wound complications were reported by 13 studies, with a 
pooled risk of wound complication 30% (19-42%), although there was considerable 
heterogeneity (I2 87.4%) (Figure 6). Average time to wound healing was reported by 7 
studies and ranged from 8 to 38 days, but was not reported in enough detail to allow pooled 
analysis. Meta regression analysis assessing the relationship between length of follow-up 
and incidence of recurrence appeared to show a relationship, but this was not statistically 
significant (Figure 7). There was no statistical evidence of publication bias (Egger’s test 
p=0.889). 
Off-midline primary closure 
Nine studies reported the outcomes of off-midline primary closure for a total of 199 patients 
(including modified Limberg flap [2,8,21,28,32,33], Karydakis [2,8,21,27] and Bascom cleft 
lift [8,20,34]). Three studies reported the outcomes of off-midline closure alone [32–34], 5 
compared it to midline primary closure [2,8,21,27,28], 3 compared it to open healing 
[2,20,21], and 1 compared it to minimally invasive techniques [8].  Overall pooled risk of 
recurrence rate for excision and off-midline primary closure is 6% (1-15%) (Figure 8). When 
analysed as a subgroup, studies with median follow-up of over 12 months had a pooled risk 
of recurrence of 8% (0-20%). There was substantial statistical heterogeneity (I2=67.8%). 
Wound complications were reported by 8 studies with pooled risk of wound complication of 
14% (6-25%) with I2 of 64.81% (Figure 9). Average time to wound healing was reported by 
only 1 study and was 27 days. There were insufficient studies to perform meta-regression or 
statistical analysis of publication bias. 
Excision + Vac therapy 
Two case series reported outcomes of VAC therapy following excision of pilonidal sinus in a 
total of 29 patients [35,36]. Overall pooled risk of recurrence was 20% (0-65%). There was 
substantial statistical heterogeneity (I2=77.5%) (Figure 10). Neither study reported any 
wound complications. Average time to wound healing ranged from 38 to 72 days, but was 
not reported in enough detail to allow further statistical analysis. There were insufficient 
studies to perform meta-regression or statistical analysis of publication bias. 
Minimally invasive techniques 
Six studies reported the results of minimally invasive approaches in 150 patients.  The three 
studies reported the outcomes of Endoscopic Pilonidal Sinus Treatment (EPSiT) [12,30,37] 
in 79 patients overall pooled risk of recurrence was 7% (1-16%, I2=24.1%) (Figure 11). There 
was one study reporting each of minimal incision [38], fibrin glue obliteration [8] and 
crystallised phenol treatment [13]. Recurrence rates for these procedures were 2.5%, 20% 
and 28.6% respectively. Wound complications were reported in 4 studies and ranged from 
0% to 10%. Time to wound healing were reported in all 3 EPSiT studies and ranged from 21-
30 days, however there was not sufficient detail reported to allow further statistical analysis. 
There were insufficient studies to perform meta-regression or statistical analysis of 
publication bias. 
Marsupialisation 
Results of marsupialisation were reported in three studies for a total of 53 patients [1,31,39]. 
All were comparative cohort studies comparing marsupialisation to midline closure and open 
healing. Overall risk of recurrence was 6% (0-22%) (Figure 12). There was substantial 
statistical heterogeneity (I2=60.6%). Wound complications were not reported for this 
procedure. Average time to wound healing was reported in all 3 studies and ranged from 6 to 
41 days, but was not reported in sufficient detail to allow further statistical analysis. There 
were insufficient studies to perform meta-regression or statistical analysis of publication bias. 
4. Discussion 
We found that evidence for the management of paediatric PNS is limited. Only 26 
publications reporting the outcomes of the management of paediatric pilonidal sinuses in 
1399 patients were identified. All of these studies were of low quality, and the majority had 
low number of participants, short follow-up periods and were of moderate to severe risk of 
bias.  
Off-midline primary closure, marsupialisation and minimally invasive techniques have the 
best outcomes for recurrence rates (6-7%), wound complications (3-14%) and average time 
to wound healing (6-41 days). 
Open wound healing and VAC therapy had the worst reported outcomes with pooled risk of 
recurrence of 26% and 20% respectively. They also had the longest reported range of 
wound healing times (38-92 and 38-72 days respectively) and open healing had the second 
highest wound complication rate (21%). 
Midline primary closure has a better pooled risk of recurrence than open healing (12% vs 
26%), and average wound healing rates comparable to marsupialisation and minimally 
invasive techniques (8-38 days). However, midline primary closure has the highest risk of 
wound complication (30%).  
In general the results reported for children are worse than those reported in adults. Stauffer 
et al [5] report recurrence rates for off-midline closure of 1.6% at 12 months rising to 6.7% at 
10 years in adults. In our study, children with median follow-up of just 25.5 months reported 
recurrence rates of 8% following off-midline closure. The results also showed different trends 
in children. Excision and open healing was found to have the worst pooled risk of recurrence 
(26%) in children, whereas in adults this procedure has the best recurrence rates(1.5% at 12 
months to 13% at 5 years [5]). There are several possible explanations for this. Doll et al [15] 
suggest that PNS in children is often more severe, especially if there is a family history. 
Furthermore it has been shown that for many other surgical procedures that high volumes 
improve outcomes [40]. Most of these studies include relatively small numbers of patients 
and it may be that the low volume of procedures being carried out has an impact on 
outcomes.  
In contrast, our findings that off-midline primary closure had better outcomes than midline 
primary closure is similar to findings of meta-analysis of PNS treatments in adults [4,5]. 
Off-midline primary closure, marsupialization and minimally invasive techniques were found 
to be comparable and have the best outcomes in terms of recurrence, wound complications 
and time to wound healing in children. With equivalent outcomes the best technique would 
be the one of these which causes least disruption to the patient, especially as recurrence 
and reoperation is more likely in children [15]. However, there is virtually no objective or 
subjective data to guide children and their parents in which of these procedures would be 
best for them.   
 The reporting of time to return to normal activities and patient satisfaction was poor across 
all studies. This information is especially important in children who may miss school and 
opportunities for social integration because of prolonged wound healing problems and 
appointments for wound dressing. Future studies should collect results of issues identified as 
being important by patients, including quality of life, time to return to normal activity and 
cosmesis.  
Although there is little data from using novel, minimally invasive techniques in children these 
may address some of the issues around impact of surgery on schooling and socialisation. 
Our study has shown these procedure to have a low risk of recurrence and following  fibrin 
glue obliteration of pilonidal sinus children returned to school after an average of just 3 days 
[9].  These procedures therefore show great promise as a generalisable treatment for PNS in 
children. 
Limitations: 
Evidence is of poor quality and limited conclusions can therefore be drawn. As there have 
been no true comparative studies it is not possible to give definite guidance on which 
technique gives the best result.  
There is obvious need for well performed, large, randomised controlled studies to further 
investigate the optimum treatment of sacrococcygeal PNS in children. It is important that 
future studies assess operative outcomes including long term recurrence rates, wound 
complication rates, time to wound healing and return to normal activities. It is equally 
important that studies assess the effect of techniques on the quality of life and patient 
satisfaction of the children treated as well as developing specific patient reported outcome 
measures to facilitate informed consent and allow children and their families to choose the 
best treatment for them. 
 
5. Conclusion 
Evidence for management of PNS in children is poor. Minimally invasive techniques, off-
midline primary closure and marsupialization have the best reported risk of recurrence, 
wound complications and time to wound healing. 
As limited evidence to guide treatment is available the effect of the chosen method on the 
patient’s quality of life should be given equal consideration. Patient counselling and choice 
should be an important part of choosing the right approach.  
Good quality research including randomised control trials is required to establish the best 
treatment option for PNS in children.  
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Figure 1. PRISMA flow diagram 
Figure 2. Risk of recurrence following excision and open healing 
Figure 3. Risk of wound complications following excision and open healing 
Figure 4. Meta-regression analysis of length of follow-up vs recurrence rate for open wound 
healing 
Figure 5. Risk of recurrence following midline primary closure 
Figure 6. Risk of wound complications following midline primary closure 
Figure 7. Meta-regression analysis of length of follow-up vs recurrence rate for midline 
primary closure 
Figure 8. Risk of recurrence following off-midline primary closure 
Figure 9. Risk of wound complications following off-midline primary closure 
Figure 10. Risk of recurrence following VAC therapy 
Figure 11. Risk of recurrence following EPSiT 
Figure 12. Risk of recurrence following Marsupialisation
Table 1: Characteristics of included studies 
Paper Year Country N 
(total) 
Median 
age 
(years) 
Gender 
 
Male   Female 
Procedure n Outcome reported Average 
follow up 
(months) 
Afsarlar et al 2013 Turkey 15 14 8 7 Off midline primary closure 15 Recurrence, complications, length 
drain in situ, length of stay 
4  
Arda et al 2005 Turkey 14 15.4 12 2 Midline primary closure  14 Recurrence, complications 3 
Ates et al  
  
2018 Turkey 117 15.6 65 52 Minimally Invasive  
(Crystallized phenol) 
40 Recurrence, complications, need for 
IV analgesia 
8.1 
Midline primary closure 77 44.6 
Braungart et 
al 
2016 UK 19 15  9 10 Midline primary closure 19 Recurrence, complications 13 
Butter et al 2006 Canada 8 NR NR NR Excision + VAC 8 Recurrence, time to wound closure Not reported 
Caniano et al 2005 USA 21 16 NR NR Excision + VAC 21 Recurrence, complications Not reported 
Eposito et al 
  
2017 Italy 15 16 9 6 Minimally invasive 
(Endoscopic) 
15 Recurrence. wound healing, pain, 
length of stay, patient satisfaction  
6 
  
Open healing 15 
Fike et al 
  
  
2011 USA 120 14.9 50 70 Midline primary closure  74 Recurrence, wound breakdown, no. 
of follow up visits 
Not reported 
  
  Off midline primary closure 18 
Other (not well defined) 21 
Gendy et al 
  
2011 
  
USA 
  
70 
  
16 
  
49 
  
21 
  
Off midline primary closure 39 Recurrence, complications, primary 
wound healing incidence 
19  
Open healing 37 45 
Gonzales et 
al 
2011 Spain 20 13.3 5 15 Midline primary closure 20 Recurrence, length of stay  Not reported 
Lee et al 
  
2008 USA 26 16.7 13 13 Marsupialisation 17 Recurrence, Time to wound closure, 
re-operative rate  
6.4  
  
Primary closure (unspecified) 9 
 Lukish et al 2009 USA 28 17.2 17 11 Midline primary closure  17 Recurrence  24.2 
  Open  healing 8   
Morden et la 
  
2005 
  
USA 
  
68 
  
13.8 
  
30 
  
38 
  
Off midline primary closure  24 Recurrence, complications 
  
49.4 
  
Midline primary closure 44 
Mutus et al 2018 Turkey 268 146 146 122 Midline primary closure 268 Recurrence, complications Not reported 
Nasr et al 
  
  
2011 Canada 121 15 64 57 Open healing 90 Recurrence, time to healing 1.2 
  
  Midline primary closure 4 
Marsupialisation 13 
Ozcan et al 
  
2017 Turkey 47 15.6 22 25 Open healing 11 Recurrence, length of stay, recovery 
time 
43.2 
  
Midline primary closure 36 
Prato et al 2018 Italy 43 15 20 23 Minimally invasive 
(Endoscopic) 
43 Recurrence, length of procedure, 
length of stay, reoperation rate 
4  
Rouch et al 
  
2016 USA 39 16 19 20 Other (not well defined) 16 Recurrence, time to healing, re-
operation 
Not reported 
  
Marsupialisation 23 
Sequeira et 
al 
  
2018 Portugal 84 16.2 61 23 Minimally Invasive  
(Endoscopic) 
21 Recurrence, complications, healing 
time,  
11.9  
  
Midline primary closure 63 
Serour et al 2002 Israel 34 16.4 20 14 Midline primary closure 34 Recurrence, complications 36 
Smith et al 
  
2015 UK 41 15 22 19 Minimally invasive 
(Fibrin glue obliteration) 
10 Recurrence, wound dehiscence 
incidence 
32 
  
Midline primary closure 5 
Off midline primary closure 26 
Speter et al 
  
2017 Israel 42   30 12 Minimally invasive  
(Minimal incision) 
21 Recurrence, postoperative 
functional outcome, Reoperation 
rate 
28 
 
50 Other (not well defined) 21 
Umesh et al 2018 USA 22 16 18 4 Off midline primary closure  22 Recurrence, complications, healing 
time, reoperation rate, patient 
satisfaction 
44 
Yamout et al 2009 USA 16 16 9 7 Off midline primary closure 54 Recurrence, complications 11 
Yildiz et al 
  
2014 Turkey 40 15.2 18 22 Midline primary closure 8 Complications, recurrence 5  
  
Off midline primary closure 32 
Zagory et al 
  
  
2016 USA 60 15 25 35 Open healing 17 Recurrence, complication, length of 
stay, re-operation rate 
53.8 
  
  Midline primary closure 36 
Off midline primary closure 7 
 
  
Table 2: Risk of bias 
Study Confoundin
g 
Selection Classification 
of Intervention 
Deviation from intended 
intervention 
Missing 
Data 
Measurement 
of Outcomes 
Reported 
Result 
Overall 
Afsarlar (2013) Moderate Low Low Low Low Moderate Moderate Moderate 
Arda (2005) Moderate Low Low Low Low Moderate Moderate Moderate 
Ates (2018) Serious Low Low Low Low Moderate Moderate Serious 
Braungart (2016) Moderate Low Low Serious Low Moderate Moderate Serious 
Butter (2006) Moderate Low Low Low Low Moderate Moderate Moderate 
Caniano (2005) Moderate Low Low Low Low Moderate Moderate Moderate 
Esposito (2017) Serious Low Low Low Low Moderate Moderate Serious 
Fike (2011) Serious Serious Serious  Low Low Moderate Moderate Serious 
Gendy (2011) Serious Low Low Low Low Moderate Moderate Serious 
Gonzalez-
Temprano (2011) 
Moderate Low Low Low Low Moderate Moderate Moderate 
Lee (2008) Serious Serious Low Low Low Moderate Moderate Serious 
Lukish (2009) Serious Serious Low Low Low Moderate Moderate Serious 
Morden (2005) Serious Serious Low Low Low Moderate Moderate Serious 
Mutus (2018) Moderate Low Low Low Low Moderate Moderate Moderate 
Nasr (2011) Serious Moderate Low Low Low Moderate Moderate Serious 
Ozcan (2017) Moderate Low Low Low Low Moderate Moderate Moderate 
Prato (2018) Moderate Low Low Low Low Moderate Moderate Moderate 
Rouch (2016) Moderate Serious Low Low Low Moderate Moderate Serious 
Sequeira (2018) Moderate Serious Low Low Moderate Moderate Moderate Serious 
Serour (2002) Moderate Low Low Low Low Moderate Moderate Moderate 
Smith (2015) Moderate Serious Low Low Low Moderate Moderate Serious 
Speter (2017) Serious Low Serious Low Moderate Moderate Moderate Serious 
Umesh (2018) Moderate Moderate Low Low Moderate Moderate Moderate Moderate 
Yamout (2009) Moderate Serious Low Low Low Moderate Moderate Serious 
Yildiz (2014) Serious Low Low Low Low Moderate Moderate Serious 
Zagory (2016) Serious Serious Low Low Low Moderate Moderate Serious 
 
  
Table 3: Summary of results 
Procedure 
No of 
studies 
Total No 
of patients 
Recurrence Wound complications Wound Healing 
  Pooled risk 
(%) 
95% CI 
(%) 
Pooled risk (%) 95% CI (%) Range  (median values - 
days) 
Open Healing 6 191 26 15-38 21 9-36 38-92 
Midline Primary 
closure 
16 728 12 8-18 30 19-42 8-38 
Off-midline primary 
closure 
9 199 6 1-15 14 6-25 27 
Excision and VAC 2 29 20 0-65 Not reported Not reported 38-72 
Minimally Invasive 
Techniques 
6 150 7 1-16 Not reported Not reported 21-30 
Marsupialisation 3 53 6 0-22 Not reported Not reported 6-41 
 
 
